Galectin Therapeutics Inc. (GALT)

[Chess Master]

this fine and dandy - we know the drug works - why is no one interested in buying the stock? It keeps getting pounded. Other theories?

This makes no sense - my only theory is the threat of financing. There I let the elephant out of the room. for the informed we know they have no inkling of diluting down here when they have about 1.5 years of runrate and a completed phase 1. and the protocol established for the phase II

there is no talk of a big pharma deal. None of the analysts focused on that did they. With NDA's in place we wont get any clarity on that for some time. But they have bee working on it for some time.